APAKAH MAKSUD METHYLPHENIDATE dalam CORSICA?
Methylphenidate
Methylphenidate adalah ubat phenethylamine dan psikostimulinan yang diguna untuk rawatan gangguan hiperaktif, defisit, sindrom tachycardia orthostatic postural dan narcolepsy. Methylphenidate telah dikaji dan diteliti selama lebih dari 50 tahun dan mempunyai rekod keberkesanan dan keselamatan yang sangat baik untuk rawatan ADHD. Paten asal itu dimiliki oleh CIBA, sekarang Novartis Corporation. Ia pertama kali dilesenkan oleh Pentadbiran Makanan dan Ubat A.S. pada tahun 1955 kerana merawat apa yang kemudian dikenali sebagai hiperaktif. Ditetapkan kepada pesakit yang bermula pada tahun 1960, dadah menjadi sangat ditetapkan pada 1990-an, apabila diagnosis ADHD sendiri menjadi lebih diterima secara meluas. ADHD dan lain-lain keadaan yang serupa dipercayai dikaitkan dengan sub-prestasi fungsi dopamin dan norepinephrine di otak, terutamanya dalam korteks prefrontal, yang bertanggungjawab untuk fungsi pengawal selia dan fungsi eksekutif. Mekanisme tindakan Methylphenidate melibatkan perencatan reinkarnasi catecholamine, terutamanya sebagai penghambat dopamin reuptake.
Definisi methylphenidate dalam kamus Corsica
Definisi methylphenidate dalam kamus adalah ubat, C14H19NO2, yang merangsang sistem saraf pusat dan digunakan, dalam bentuk hidroklorida, untuk merawat narkolepsi serta gangguan defisit perhatian.
CORSICA BUKU YANG BERKAIT DENGAN «METHYLPHENIDATE»
Ketahui penggunaan
methylphenidate dalam pilihan bibliografi berikut. Buku yang berkait dengan
methylphenidate dan ekstrak ringkas dari yang sama untuk menyediakan konteks penggunaannya dalam kesusasteraan Corsica.
1
ADHD Comorbidities: Handbook for ADHD Complications in ...
In addition, stimulants (amphetamines more than methylphenidate) increase
levels of norepinephrine and serotonin in the interneuronal space, although
compared with their effects on dopamine, these effects are relatively minor (
Kuczenski ...
2
The Effects of
Methylphenidate on Behavior and Neural ...
It has been shown that adult animal exposed to perinatal anoxia (or oxygen deprivation at the time of birth) are hyperactive compared to controls (Brake, Boksa, & Gratton 1997a).
3
Lewis's Child and Adolescent Psychiatry: A Comprehensive ...
The most commonly used stimulants for the treatment of ADHD include
methylphenidate, dextroamphetamine, and the mixed preparation of D,L-
amphetamine (33). Immediate- release methylphenidate has been studied more
carefully than the ...
Andrés Martin, Fred R. Volkmar, Melvin Lewis,
2007
4
Lexicon of Psychiatry, Neurology, and the Neurosciences
methylphenidate + imipramine methylphenidate/right hemisphere processing
methylphenidate + imipramine Methylphenidate (MPH) can raise imipramine (IMI
) plasma level and potentiate its anti- depressant effects (Wharton RN, et al.
5
The Science of ADHD: A Guide for Parents and Professionals
The illicit use of methylphenidate for cognitive enhancing effects should be
distinguished from the question of its addictiveness – there is a greater similarity
with caffeine rather than cocaine. Here we have the use of methylphenidate for a
...
6
Side Effects of Drugs Annual: A worldwide yearly survey of ...
[51] Repantis D, Schlattmann P, Laisney O, Heuser I. Modafinil and
methylphenidate for neuroenhancement in healthy individuals: a systematic
review. Pharmacol Res 2010; 62: 187–206. [52] Balázs J, Dallos G, Keresztény A
, Czobor P, ...
7
Nicotine and
Methylphenidate on Adolescent Brain Development ...
To our knowledge this is the first study that has shown long-term behavioral and neurochemical changes stemming from very low chronic exposure of these two commonly co-consumed stimulants during adolescence.
8
Concepts of Chemical Dependency
Within the brain, methylphenidate blocks the molecular dopamine reuptake
pump5 in the neural wall, allowing the dopamine molecules to remain in the
synaptic junction longer, enhancing their effect (Volkow et al., 1998; Volkow &
Swanson, ...
9
Worst Pills, Best Pills: A Consumer's Guide to Avoiding ...
FDA:BLACK BOX WARNING: DRUG ABUSE AND DEPENDENCE
Methylphenidate should be given cautiously to emotionally unstable patients,
such as those with a history of drug dependence or alcoholism, because such
patients may ...
10
Dulcan's Textbook of Child and Adolescent Psychiatry
The studies reviewed suggest these deficits attenuate over time, even with
continued treatment, and do not differ between methylphenidate and
amphetamine or between long- and short-acting formulations. Some studies
suggest that ADHD ...
BARANGAN BERITA YANG TERMASUK TERMA «METHYLPHENIDATE»
Ketahui apa yang diterbitkan oleh akhbar nasional dan antarabangsa dan cara istilah
methylphenidate digunakan dalam konteks perkara berita berikut.
What is Modafinil – Is Provigil The Most Effective Nootropic
Examples of Schedule II drugs include Actiq, morphine, methadone and methylphenidate (Ritalin). Examples of Schedule III drugs include ... «Gazette Review, Jul 15»
Shire PLC 19.5% Potential Upside Indicated by JP Morgan Cazenove
... a single-entity amphetamine), INTUNIV (extended release guanfacine), EQUASYM (methylphenidate hydrochloride) modified release (XL), ... «DirectorsTalk Interviews, Jul 15»
Daytrana Skin Discoloration Could Be the Color of Money for Plaintiffs
Daytrana (methylphenidate) is a pharmaceutical manufactured by Noven Pharmaceutical Inc. and used to treat attention deficit hyperactivity ... «LawyersandSettlements.com, Jul 15»
Police: Robber left behind demand note with his fingerprints on it
Methylphenidate, Oxycodone and Suboxone. The pharmacists gave the robbers what they wanted, but they left behind that demand note. «wreg.com, Jul 15»
Concerns over ADHD medicine supply
Almost all of the growth in ADHD medications relates to increasing use of methylphenidate, with most of these scripts being for the modified ... «Pharmacy News, Jul 15»
Neos Therapeutics (NEOS) Plans to Raise $60 Million in July 23rd IPO
We have a Prescription Drug User Fee Act, or PDUFA, goal date of November 9, 2015 for NT-0102, our methylphenidate XR-ODT. A PDUFA ... «WKRB News, Jul 15»
Pfizer (PFE) Announces FDA Acceptance of Methylphenidate HCI …
Pfizer (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for ... «StreetInsider.com, Jul 15»
Shire PLC 95.2% Potential Decrease Indicated by RBC Capital …
... a single-entity amphetamine), INTUNIV (extended release guanfacine), EQUASYM (methylphenidate hydrochloride) modified release (XL), ... «DirectorsTalk Interviews, Jul 15»
Neos Therapeutics on deck for IPO (NEOS)
The New Drug Application (NDA) for NT-0102, methylphenidate XR-ODT, has been submitted to and accepted for review by the FDA. «Seeking Alpha, Jul 15»
Highland Therapeutics Announces Formation of U.S. Commercial …
IPA will be responsible for the commercialization of HLD-200 (next-generation formulation of methylphenidate), HLD-100 (next-generation ... «Business Wire, Jul 15»